Duo Hong

ORCID: 0000-0001-8604-4159
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • MicroRNA in disease regulation
  • Cancer-related molecular mechanisms research
  • Nanoparticle-Based Drug Delivery
  • Nanoplatforms for cancer theranostics
  • RNA modifications and cancer
  • Fibroblast Growth Factor Research
  • Cancer Genomics and Diagnostics
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Lung Cancer Treatments and Mutations
  • Indoor and Outdoor Localization Technologies
  • Bluetooth and Wireless Communication Technologies
  • Phytochemical Studies and Bioactivities
  • Wnt/β-catenin signaling in development and cancer
  • Gold and Silver Nanoparticles Synthesis and Applications
  • Digital Imaging for Blood Diseases
  • MXene and MAX Phase Materials
  • Cancer, Hypoxia, and Metabolism
  • Natural product bioactivities and synthesis
  • Kruppel-like factors research
  • Wireless Networks and Protocols
  • Sepsis Diagnosis and Treatment
  • Lanthanide and Transition Metal Complexes
  • Autophagy in Disease and Therapy
  • Brain Tumor Detection and Classification
  • Intensive Care Unit Cognitive Disorders

Daping Hospital
2024

Wuhan University
2024

Army Medical University
2024

Zhongnan Hospital of Wuhan University
2024

Shanghai Jiao Tong University
2017-2023

Shanghai Ninth People's Hospital
2017-2023

National Clinical Research Center for Digestive Diseases
2023

First Hospital of China Medical University
2017-2022

China Medical University
2017-2022

Stomatology Hospital
2017

Background This study aims to systematically assess the risk factors, overall strength of association, and evidence quality related sepsis-associated encephalopathy. Methods A systematic search was conducted in Cochrane Library, PubMed, Web Science, Embase for cohort or case-control studies published up August 2023 on factors associated with sepsis-related The selected were screened, data extracted, evaluated using Newcastle–Ottawa Scale. Meta-analysis performed RevMan 5.3 software....

10.3389/fmed.2024.1379019 article EN cc-by Frontiers in Medicine 2024-05-21

Respiration rate is an important healthcare indicator, and it has become a popular research topic in remote applications with Internet of Things. Existing respiration monitoring systems have limitations terms convenience, comfort, privacy, etc. This paper presents contactless real-time system, the so-called Wi-Breath, based on off-the-shelf WiFi devices. The system monitors both amplitude phase difference channel state information (CSI), which sensitive to human body micro movement. CSI...

10.1109/jbhi.2022.3186152 article EN IEEE Journal of Biomedical and Health Informatics 2022-06-24

In precision cancer nanomedicine, the key is to identify oncogenes that are responsible for tumorigenesis, based on which these genetic drivers can be each specifically regulated by a nanovector-directed, oncogene-targeted microRNA (miRNA) tumor suppression.Fibroblast Growth Factor Receptor 3 (FGFR3) such an oncogene.The molecular tumor-subtype harboring FGFR3 genomic alteration has been identified via sequencing and referred as FGFR3-driven tumors.This genomics-based classification provides...

10.7150/thno.16357 article EN cc-by Theranostics 2017-01-01

Mitogen-inducible gene 6 (Mig-6) is a tumor suppressor that plays an important role in many types of cancers by interacting with EGFR.However, its molecular mechanism hepatocellular carcinoma (HCC) and relationship miRNAs need to be elucidated.Therefore, this study aimed explore whether Mig-6 could promote apoptosis the inhibition autophagy via downstream miRNA HCC cell lines.We used two lines, HepG2 HLE, establish overexpression knockdown experiments, as well miR-193a mimic inhibitor...

10.7150/ijms.66040 article EN cc-by-nc International Journal of Medical Sciences 2022-01-01

The fibroblast growth factor receptor (FGFR) members including FGFR1-4 have been identified as promising novel therapeutic targets and prognostic markers in multiple solid tumors. However, the predictive role of expression FGFR proteins oral squamous cell carcinoma (OSCC) requires further exploration.

10.1111/odi.14542 article EN Oral Diseases 2023-03-20

Tyrosine kinase inhibitors (TKIs) are standard first-line treatments for advanced non-small-cell lung cancer (NSCLC) with driver gene mutations. The Response Evaluation Criteria in Solid Tumors (RECIST) limited predicting long-term patient benefits. A tumour marker-based evaluation criteria, RecistTM, was used to investigate the potential assessing targeted-therapy efficacy treatment. We retrospectively analysed patients stage IIIA–IV NSCLC and mutations, whose baseline marker levels...

10.1016/j.neo.2024.101006 article EN cc-by-nc-nd Neoplasia 2024-05-17

Abstract Background: Mitogen-inducible gene 6 ( Mig-6 ) is a tumor suppressor that plays an important role in many types of cancers by interacting with EGFR. Thus far, little known about the molecular mechanism hepatocellular carcinoma (HCC). Also, relationship between and miRNAs needs to be elucidated. Therefore, this study first aimed find whether could promote apoptosis inhibition flux autophagy its downstream miRNA HCC cell lines. Methods: Two lines, HepG2and HLE, were used study....

10.21203/rs.3.rs-39528/v1 preprint EN cc-by Research Square (Research Square) 2020-07-09
Coming Soon ...